Tweet from gbosslet at February 18, 2022 at 06:24PM
Ivermectin did not outperform usual care in the I-tech trial
Ivermectin has yet to prove clinical efficiency in any well done trial
ACTIV-6 initial ivermectin arm (400 mcg/kg x 3 days) has completed enrollment and data should come soon https://t.co/0i89955ajX
— Gabriel Bosslet (@gbosslet)
Feb 19, 2022
from http://twitter.com/gbosslet